Measuring Antimicrobial Efficacy against Biofilms: a Meta-analysis

Antimicrobial Agents and Chemotherapy
Philip S Stewart, Albert E Parker

Abstract

Through a statistical meta-analysis of published data on antimicrobial efficacy against biofilms formed by two common bacterial species, it was concluded that the particular experimental method used is the most important factor determining the outcome of the test. An expected dose-response relationship (greater killing with higher doses or longer treatment times) was observed for data sets derived from a single method but was not observed when data from multiple studies using diverse methods were pooled. Method-specific properties such as the surface area/volume ratio, areal biofilm cell density, and microbial species were shown to influence quantitative measurements of biofilm killing. A better appreciation of the method characteristics that affect antibiofilm efficacy tests could aid decision-making related to investment in research and development and regulatory approvals for biofilm control strategies. The following recommendations are offered to those working in research and development related to biofilm control: (i) report the log reduction, surface area/volume ratio, and biofilm areal cell density; (ii) include data for a benchmark agent, making sure that this agent performs competitively at the dose tested; (iii) measu...Continue Reading

References

Jul 1, 1992·Canadian Journal of Microbiology·H AnwarJ W Costerton
Nov 1, 1989·The Journal of Antimicrobial Chemotherapy·H AnwarJ W Costerton
Oct 3, 1999·Applied and Environmental Microbiology·J G ElkinsT R McDermott
Feb 2, 2000·Applied and Environmental Microbiology·P S StewartD J Hassett
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·C CampanacC Roques
Aug 30, 2002·Applied and Environmental Microbiology·Suzanne B I LuppensTjakko Abee
Mar 20, 2004·Nature Reviews. Microbiology·George L Drusano
Mar 11, 2005·Microbiology·Darla M GoeresRodney M Donlan
May 26, 2007·Journal of Microbiological Methods·Kelli Buckingham-MeyerMartin A Hamilton
May 12, 2009·Journal of Medical Microbiology·Antonia NostroGiuseppe Bisignano
Nov 19, 2010·BMC Microbiology·James P FolsomPhilip S Stewart
Sep 3, 2011·Journal of Applied Microbiology·A M AgostinhoG A James
Sep 14, 2011·Antimicrobial Agents and Chemotherapy·Brian J MorrowA Simon Lynch
Aug 28, 2013·Antimicrobial Agents and Chemotherapy·Ken-ichi OkudaYoshimitsu Mizunoe
Jul 1, 2012·Brazilian Journal of Microbiology : [publication of the Brazilian Society for Microbiology]·Tatiane Karen CabeçaElisabeth Loshchagin Pizzolitto
May 13, 2014·Journal of Microbiological Methods·A E ParkerA Omar
Sep 6, 2014·Current Pharmaceutical Design·Gilles Brackman, Tom Coenye
Oct 5, 2014·Food Science and Technology International = Ciencia Y Tecnología De Los Alimentos Internacional·Daniel Vázquez-SánchezJuan J Rodríguez-Herrera
Dec 2, 2014·Pathogens·Mary Anne Roshni Amalaradjou, Kumar Venkitanarayanan
Jun 2, 2015·Current Medicinal Chemistry·Anabela BorgesManuel Simões
Jul 18, 2015·Microbiology Spectrum·Philip S Stewart
Jul 28, 2015·International Journal of Antimicrobial Agents·Kelly R KirkerGarth A James
Sep 8, 2015·Pharmaceuticals·Philip S Stewart
Sep 10, 2015·Microbiology Spectrum·Liang Yang, Michael Givskov
Feb 13, 2016·Clinical Oral Implants Research·Arifo WidodoNikolaos Donos
May 14, 2016·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·Virginia PostT Fintan Moriarty
Nov 22, 2016·Critical Reviews in Microbiology·Joana AzeredoClaus Sternberg
Apr 4, 2017·FEMS Microbiology Reviews·Clayton W Hall, Thien-Fah Mah

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biofilm & Infectious Disease

Biofilm formation is a key virulence factor for a wide range of microorganisms that cause chronic infections.Here is the latest research on biofilm and infectious diseases.

Biofilms

Biofilms are adherent bacterial communities embedded in a polymer matrix and can cause persistent human infections that are highly resistant to antibiotics. Discover the latest research on Biofilms here.

CRISPR Screens in Drug Resistance

CRISPR-Cas system enables the editing of genes to create or correct mutations. This feed focuses on the application of CRISPR-Cas system in high-throughput genome-wide screens to identify genes that may confer drug resistance.